Higenamine inhibits apoptosis and maintains survival of gastric smooth muscle cells in diabetic gastroparesis rat model via activating the β2-AR/PI3K/AKT pathway-Reference-Cited by-同舟云学术

Higenamine inhibits apoptosis and maintains survival of gastric smooth muscle cells in diabetic gastroparesis rat model via activating the β2-AR/PI3K/AKT pathway

Published:2017-11 Issue: Volume:95 Page:1710-1717
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

An Xiaoxia,Long Chunli,Deng Xiaomin,Tang Aihua,Xie Junyan,Chen Li,Wang Zhengang

Funder

Guangxi Zhuang Autonomous Region Health and Family Planning Commission

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference39 articles.

1. Advances in diabetic gastroparesis;Camilleri;Rev. Gastroenterol. Disord.,2002

2. Clinical guideline: management of gastroparesis;Camilleri;Am. J. Gastroenterol.,2013

3. Gastrointestinal motility disorders in patients with diabetes mellitus;Abrahamsson;J. Intern. Med.,1995

4. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life;Talley;Am. J. Gastroenterol.,2001

5. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease;Vinik;J. Diabetes Invest.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A. officinarum Hance – P. cablin (Blanco) Benth drug pair improves oxidative stress, intracellular Ca2+ concentrations and apoptosis by inhibiting the AGE/RAGE axis to ameliorate diabetic gastroparesis: In vitro and in vivo studies;Journal of Ethnopharmacology;2024-04

2. Alpinia officinarum Hance extract ameliorates diabetic gastroparesis by regulating SCF/c-kit signaling pathway and rebalancing gut microbiota;Fitoterapia;2024-01

3. Exploring the Underlying Mechanism of Alpinia officinarum Hance Ameliorating Diabetic Gastroparesis through Combining Network Pharmacology, Molecular Docking, and in Vivo Experimental Verification;Frontiers in Bioscience-Landmark;2023-08-11

4. LKB1: An emerging therapeutic target for cardiovascular diseases;Life Sciences;2022-10

5. Pharmacological effects of higenamine based on signalling pathways and mechanism of action;Frontiers in Pharmacology;2022-09-15